1.Association between cholesteryl ester transfer protein-TaqIB polymorphism and coronary heart disease
Chinese Journal of Postgraduates of Medicine 2009;32(34):1-5
Objective To determine the frequency of the cholesteryl ester transfer protein (CETP)-TaqIB polymorphism and investigate its relationship with plasma lipid levels and coronary hert disease(CHD). Methods Two hundred and thirty-eight patients with CHD (CHD group) and 203 age-matched controls( control group) were selected, the CETp-TaqIB mutation was detected by restriction fragment length polymorphism of the CETP gene. Results In the total subjects, the frequency of B1 and B2 alleles were 59.4%(262/441 ) and 40.6%( 179/441 ) respectively. Compared with that in control group, the frequency of CETP genotype BIBI was higher in CHD group [39.9%(95/238) vs 29.6% ( 60/203 ), P<0.05], and the frequency of B1B2 was lower in CHD group [44.1%(105/238) vs 53.7%(109/203), P< 0.05]. Compared with that in the B2 homozygotes, high density lipoprotein cholesterol (HDL-C) and apolipoprotein (apo)A I level were significantly lower in the B1 homozygotes [(1.19±0.36) mmol/L vs (1.38±0.39) retool/L,( 1.17±0.33 ) g/L vs ( 1.30±0.31 ) g/L, P<0.05]. The B 1 homozygotes was associated with higher degree of cononary stenosis than the B2 carriers (P<0.05 ). There was no significant association between CETP-TaqIB genotype and the risk of CHD (P=0.147). Conclusions CETP-TaqIB polymorphism affects the concentrations of lipaproteins. There are significant associations between the B1 homozygotes and lowerHDL-C and apo A I levels. The B1 allele is not an independent risk factor for CHD.
2.Application of omeprazole combined with psychological intervention in the treatment of peptic ulcer disease
Chinese Journal of Biochemical Pharmaceutics 2017;37(9):232-233
Objective To explore the clinical application of omeprazole combined with psychological nursing intervention in the treatment of peptic ulcer. Methods 80 patients with peptic ulcer treated in our hospital from April 2014 to October 2016 were selected, and randomly divided into control group and experimental group, 40 patients in each group. The control group was treated with omeprazole, amoxicillin and tinidazole, and the experimental group was treated with psychological nursing intervention based on the treatment of the control group. Both groups were treated for four weeks in a row. The clinical efficacy and the recurrence rate after treatment were followed up to half a year after treatment in two groups were compared. Results After four weeks of treatment, the total effective rate in experimental group was 92.5%, which was significantly higher than that in the control group (P<0.05). After six months of follow-up, the recurrence rate of patients in the experimental group was significantly lower than that in the control group, and the difference was statistically significant (P<0.05). Conclusion Patients with peptic ulcer treated with omeprazole combined with psychological nursing intervention, the effect is significant, relieve the patient's clinical symptoms, effectively improve the clinical cure rate of peptic ulcer recurrence rate is low, high security, is worth popularization and application in clinic.
3.The correlation between serum concentrations of apolipoprotein A5 and levels of fasting insulin and adiponectin in patients with coronary heart disease
Huan LIU ; Xiangping LI ; Shuiping ZHAO
Chinese Journal of Practical Internal Medicine 2006;0(22):-
Objective To explore the change of serum concentrations of apolipoprotein A5(APOA5),and the relationship with levels of adiponectin and fasting insulin(FINS)in patients with coronary heart disease(CHD).Methods Blood lipids,the serum concentrations of APOA5,adiponectin and insulin were examined in 95 individuals,who were divided into two groups:51 patients with CHD and 44 healthy individuals.Results The concentrations of APOA5 and adiponectin in CHD patients were significantly lower than the healthy individuals[(230.06?115.8)?g/L and(3.03?1.85)?g/L vs(324.43?151.79)?g/L and(4.12?2.48)?g/L respectively,all P
4.Hepatectomy for hepatic metastasis in 32 gastric cancer patients
Shuiping YU ; Siwei LI ; Jun WENG ; Bo LI ; Bingzong HOU
Chinese Journal of General Surgery 2014;29(3):185-187
Objective To evaluate hepatectomy for liver metastasis in patients of gastric carcinoma.Methods Clinical data of 32 gastric cancer cases undergoing hepatectomy for hepatic metastatic tumor were reviewed retrospectively from 2006 to 2012.16 cases underwent radical gastrectomy and synchronous hepatectomy for liver metastasis,the remaining 16 cases underwent radical resection of gastric cancer and liver resection heterochronously.The relationship between prognosis and clinicopathology was analyzed.Results The overall survival rates were 84%,50% and 37% in 1 year,3 years and 5 years.The median survival time was 32 months.Gastric cancer invasion depth,intravascular tumor thrombi,lymphatic metastasis and intraoperative blood transfusion was related to poor prognosis by single factor analysis,while gastric serosal invasion,tumor thrombus and liver metastasis tumor > 5 cm related to poor prognosis by multiple factors analysis.Conclusions Gastric cancer patients with liver metastasis who underwent hepatic resection can achieve good prognosis if hepatic metastatic tumor < 5cm or the primary gastric cancer does not invade the serosa and without tumor thrombus.
5.Effectivity of N -acetylcysteine effervescent tablets combined with tiotropium bromide powders for inhalation in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease
Jiajun LI ; Tian TIAN ; Shuiping MENG ; Lailing LI
Chinese Journal of Primary Medicine and Pharmacy 2016;23(21):3213-3216
Objective To explore the effectively of N -acetylcysteine effervescent tablets combined tiotropium bromide powders for inhalation in treatment of patients with acute exacerbation of chronic obstructive pulmonary disease. Methods 72 patients with acute exacerbation of chronic obstructive pulmonary disease were randomly divided into control group(36 cases)and treatment group(36 cases)according to random number table method.In treatment group,patients were given N -acetylcysteine effervescent tablets(600mg,2 times/d,oral)and tiotropium bromide powders for inhalation(18 μg,one time /d)for a month,and in the control group,patients were given tiotropium bromide powders for inhalation (18 μg,one time /d).Pulmonary function and clinical changed symptoms were observed as evaluation index before and after treatment in patients of the two groups Results The total effective rate were 61.1%,83.3% in the treatment group and control group respectively,there was a statistically significant difference (χ2 =4.430,P =0.035).Before the treatment,there was no significant differences between the two groups of patients with pulmonary function(P >0.05).After a month,pulmonary function of patients′FEV1 ,FVC and FEV1 /FVC in the treatment group were (1.9 ±0.6)L,(3.1 ±0.3)L and (67.9 ±8.4)% respectively,which in the control group were (1.6 ±0.5)L,(2.7 ±0.2)L and (59.3 ±7.4)%,there were significant differences(t =2.304,6.564,4.609, P =0.021,0.000,0.000).Conclusion N -acetylcysteine effervescent tablets combined with tiotropium bromide powders for inhalation can improve the clinical curative effect for patients with acute exacerbation of chronic obstructive pulmonary disease,which can be used to improve the patients'clinical symptoms and pulmonary function.
6.Clinical Observation of Butylphthalide Combined with Nimodipine in the Treatment of Vascular Cognitive Im-pairment
Jiwen JIANG ; Shuiping LIU ; Xiaoqing LI ; Congjia LI
China Pharmacy 2015;(21):2909-2910,2911
OBJECTIVE:To investigate the clinical efficacy and safety of butylphthalide combined with nimodipine in the treat-ment of vascular cognitive impairment. METHODS:Totally 156 patients with vascular cognitive impairment were randomly divided into control group and observation group. All patients were given anti-platelet,control of blood pressure,lowering blood glucose, lowering statin therapy for stable plaque and symptomatic treatment. On this basis,control group was orally treated with nimodipi-he 30 mg,tid;observation group was orally treated with Butylphthalide capsule 0.2 g based on the treatment of control group,tid. The course lasted for 3 months. The clinic data was observed,including clinical efficacy,and Montreal cognitive assessment(Mo-CA)score,activities of daily living scale(ADL)score,stenosis great vessels distal blood flow velocity and incidence of adverse reactions before and after treatment. RESULTS:The total effective rate in observation group was significantly higher than control group,with significant difference(P<0.05). After treatment,the MoCA score,ADL score and stenosis great vessels distal blood flow velocity in 2 groups were significantly higher than before,and observation group was higher than control group,with signifi-cant differences(P<0.05). There were no obvious adverse reactions during treatment. CONCLUSIONS:Based on the conventional treatment,butylphthalide combined with nimodipine has better efficacy than nimodipine alone in the treatment of vascular cognitive impairment,and can improve the stenosis great vessels distal blood flow velocity better,with similar safety.
7.Optimal time point to measure postprandial hypertriglyceridemia after a high-fat meal
Ling LIU ; Shuiping ZHAO ; Yanchun CHENG ; Yuling LI
Chinese Journal of Endocrinology and Metabolism 1985;0(01):-
Objective To study the change of postprandial triglyceride (TG) concentrations after a high-fat meal in patients with coronary heart diseases (CHD), patients with essential hypertension (EHP) and healthy controls, and to explore the optimal time point to measure postprandial TG metabolism. Methods Fifty-four CHD patients, thirty-six EHP patients and twenty-five healthy controls were recruited. The concentrations of serum TG in fasting state and at 2, 4, 5, 7 h after a single high-fat meal (800 kcal, including 50 g fat) were measured. Results The postprandial serum TG concentrations increased significantly at 2, 4, 5 h point in all subjects (all P
8.Effects and mechanism of simvastatin and fenofibrate on the expression of hepatic apolipoprotein M in mice
Liu YANG ; Shuiping ZHAO ; Saidan ZHANG ; Tie LI
Journal of Chinese Physician 2010;12(11):1474-1477
Objective To examine the effects and mechanisms of simvastatin and fenofibrate, and combination of the two drugs on the expression of apolipoprotein M (apoM). Methods The male C57BL/6N mice ( n =32) were random divided into four groups, including control group (with no special treatment), statin group (with simvastatin [10mg/( kg · d) for 4 weeks], fibrate group (with fenofibrate [100mg/( kg · d) for 4 weeks] and combination group ( with simvastatin [10mg/( kg· d)] and fenofibrate [100mg/( kg · d) for 4 weeks]. The levels of apoMmRNA and protein, hepatic nuclear factor (HNF-1α)mRNA, liver X receptor-α (LXRα) mRNA in mouse liver were measured. Results Both of simvastatin and fenofibrate can increase the expression of apolipoprotein M ( 1.97 ± 0. 04,2. 02 ± 0. 02 ) and HNF-1αmRNA ( 1.74 ± 0. 05,1.71 ± 0. 04). Combination group obtained more effects than either single agent ( P < 0. 05 ). Simvastatin could decrease the expression of LXRα mRNA ( 1.00 ± 0. 02 ) ( P < 0. 05 ). Fenofibrate could increase the expression of LXRα mRNA(2. 80 ±0. 04) ( P <0. 05). No significant difference in LXRα expression was seen between combination( 1.56 ±0. 03 ) and control group( 1.53 ±0. 03 )( P >0. 05). Conclusions Simvastatin and fenofibrate can increase apoM expression. Treatment with combination of the two drugs is more effective, and the mechanism might be related to the regulation of HNF-1α and LXRα.
9.Diagnostic value of pentraxins-3 and triglyceride/high-density lipoprotein cholesterol in acute coronary syndrome
Li ZHANG ; Qiming LIU ; Shenghua ZHOU ; Haibin QIN ; Shuiping ZHAO
Chinese Journal of Postgraduates of Medicine 2010;33(31):1-3
Objective To investigate the value of serum pentraxins-3 (PTX-3) together with triglyceride (TG)/high-density lipoprotein cholesterol (HDL-C) as predictor risk factors of future acute coronary syndrome(ACS). Methods One hundred and seventy-one cases of selective coronary angiography from July 2008 to December 2009 were collected and analyzed. According to the situation on admission and coronary angiography, patients were divided into three groups: normal control group (25 cases), stable angina pectoris (SAP) group (23 cases) and ACS group (123 cases). Fasting venous blood was extracted for measuring serum PTX-3 and lipids (TG, HDL-C) in the next morning, and the statistical significanc was analyzed. Results The level of serum PTX-3 and the ratio of TG to HDL-C in ACS group [(6.39 ± 3.01)μ g/L, 2.38 ± 2.00] were significantly higher than those in SAP group[(3.87 ± 2.05 ) μ g/L, 1.70 ± 1.01] and normal control group [(2.90 ± 1.94)μg/L,0.95 ±0.35] (P <0.01 or <0.05). Conclusion Increased serum PTX-3 levels and ratio of TG to HDL-C in patients are closely related with ACS, both of which increase the accuracy of early diagnosis of ACS.
10.Gene quasispecies analysis of transfusion transmitted virus DNA in two patients with transfusion transmitted virus infection
Zhouhua HOU ; Deming TAN ; Yutao XIE ; Shuiping LIU ; Congzhi LI
Journal of Chinese Physician 2001;0(09):-
Objective To investigate gene variation and the relationship between gene variation and pathogenicity of transfusion transmitted virus(TTV).Methods The TTV DNA in the serum sample from a blood donor(BD) and a chronic non-A-G severe hepatitis(CSH) patient with TTV infection was amplified by using PCR.The purified PCR product was cloned and 10 clones from each case were sequenced.The sequences were compared among different clones and analyzed by Phylogentic tree.Results There were two different TTV strains in the BD and seven different TTV strains in the chronic non-A-G severe hepatitis patient.The TTV clones in the BD were of G1a subtype and those of the CSH were of G1a and G1b subtype.Conclusion Gene variant of TTV was much more complicated in the CSH patients than that in the BD ones.